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ABSTRACT
The objective of this study was to determine the prevalence of HPV infection and cervical lesions present in women 
who attended a health center in a low-resource area of the city of Posadas, Misiones, Argentina. Cervical cell samples 
(n = 163) were processed for Papanicolaou cytology and HPV-PCR tests. Socio-cultural risk factors were estimated 
using the odds ratio (OR, CI 95 %). Cervical lesions were detected in 14.7 % of women. The general prevalence of 
HPV infection was of 38 %. The most common types among the total population were HPV-16 (9.8 %) and HPV-33 (9.3 
%). HPV-16 was detected in association with 29.2 % and 6.5 % of women with and without cervical lesions, respec-
tively, the OR being 5.3 (1.8-15.8). Risk factors for HPV-16 infection were a smoking habit and a history of previous 
sexually-transmitted diseases. These data are important for the implementation of prevention programs, including an 
appropriate introduction of vaccination and the baseline for virological surveillance in the vaccine era.
Key words: Human papillomavirus (HPV); screening; cervical cancer
RESUMEN
Detección del virus papiloma humano (HPV) y citología de Papanicolaou en mujeres de bajos recursos de la 
ciudad de Posadas, Misiones, Argentina. El objetivo de este estudio fue determinar la prevalencia de la infección 
por HPV y de lesiones cervicales en mujeres asistidas en un centro de salud situado en un área de bajos recursos 
de la ciudad de Posadas, Misiones, Argentina. Las muestras (n = 163) fueron examinadas mediante las pruebas de 
Papanicolaou y de PCR para HPV. Los factores socio-culturales de riesgo fueron identificados mediante el cálculo 
de la odds ratio (OR, IC 95 %). Se detectaron lesiones cervicales en el 14,7 % de las mujeres. La prevalencia de 
infección por HPV fue de 38 %. Los tipos más frecuentes en la población total fueron HPV-16 (9,8 %) y HPV-33 
(9,3 %). El HPV-16 se detectó asociado al 29,2 % y al 6,5 % de las mujeres con lesiones del cuello uterino y sin ellas, 
respectivamente, con un OR de 5,3 (1,8-15,8). Los factores de riesgo para la infección por HPV-16 fueron el hábito 
de fumar y el antecedente de enfermedades de transmisión sexual. Estos datos son importantes para la ejecución 
de los programas de prevención, incluyendo una introducción adecuada de la vacunación y la línea de base para la 
vigilancia virológica en la era de la vacuna.
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The relationship between Human papillomavirus (HPV) 
genital infections and the development of cervical cancer 
is firmly established. Currently, more than sixteen HPV 
types are considered high-risk types for cervical cancer 
(Papillomaviridae family, Alpha Papillomavirus genus, 
species A6, A7 and A9) (6). 
Cervical cancer is the second most frequent cancer 
in women in Argentina. Current estimates indicate that 
3,996 women are diagnosed with cervical cancer and 
that 1,809 die every year (15). The Province of Misiones 
is considered a region with high mortality rates for cervical 
carcinoma (15.5/100,000) compared to urban areas of 
the country such as Buenos Aires city (6.3/100,000) (2). 
Epidemiological studies performed locally in women with 
normal cytology have shown HPV prevalence of 43 % in 
a white urban population and of 64 % in an indigenous 
Guaraní population (13). Therefore, screening for cervical 
cancer remains an important health concern throughout 
the region; the efforts must ensure that all women have 
access to preventive services including educational health, 
Papanicolaou (Pap) screening and HPV vaccines.  
The present study was conducted at Nueva Esperanza, 
a recently established neighborhood in Posadas city, as 
part of a relocalization program associated with the con-
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struction of the Yacyreta Dam. In this neighborhood live 
more than 1,000 low income families originally settled on 
the coast of the Paraná River until 2001. Although Nueva 
Esperanza has a peripheral health center, the nearest 
public hospital is located 10 km away; this distance and 
the cost of public transportation limit the population’s ac-
cess to regular gynecological care. The objective of this 
study was to determine the prevalence of HPV infection 
and cervical lesions present in women who attended a 
health center in a low-resource area of the city of Posadas, 
Misiones, Argentina.
The project was carried out during 2005-2006 at the 
community health center. The inclusion criteria limited the 
study to sexually active women. Nuevo Esperanza neigh-
borhood contains approximately 6,000 people. Data about 
sexually active women were unknown and therefore was 
calculated indirectly using local references (http://www.
indec.gov.ar/). We estimated that 1,620 women over 15 
years old were under this condition (27 % of the total 
population). A total of 170 participants who gave their in-
formed consent were included in the study. A standardized 
questionnaire was given to each participant to determine 
economic status, educational level, smoking habits, sexual 
behavior (first sexual intercourse age and number of lifetime 
sexual partners), parity, and history of sexually transmitted 
diseases (STDs). All procedures were performed in ac-
cordance with the Helsinki Declaration and the study was 
approved by the Comité de Bioética, Departamento de 
Docencia e Investigación del Hospital Escuela de Agudos 
Dr. Ramón Madariaga (Posadas, Argentina). Samples 
consisting of endo-ectocervical cells were collected with 
wooden spatulas for Pap smears and with cytobrushes for 
HPV-DNA analysis. 
The Pap smears were classified as: 1) negative for 
intraepithelial lesion or malignancy (NILM); 2) low-grade 
squamous intraepithelial lesion (L-SIL); 3) high-grade squa-
mous intraepithelial lesion (H-SIL); and 4) invasive squamous 
cell carcinoma (ISCC). If cervical lesions were detected, the 
patient was referred to Hospital Dr. Ramón Madariaga for a 
complementary biopsy and eventual treatment. 
For HPV DNA analysis, genomic DNA was extracted 
from cervical cells using standard methods. Sample 
quality was tested by PCR targeted to 268 base pairs 
(bp) of the human beta-globin gene using primers GH20 
(5´-GAAGAGCCAAGGACAGGTAC-3´) and PG04 
(5´-CAACTTCATCCACGTTCACC-3´). HPV was detected 
with MY09 and MY11 consensus primers (3). HPV typing 
was based on the E6-Nested Multiplex PCR protocol (E6-
NMPX) (11). Samples that failed to be typed by E6-NMPX 
were subjected to RFLP analysis (3).
The association between socio-cultural risk factors 
and cervical lesion grade, HPV or HPV-16 infection was 
assessed by univariate analysis (odds ratios; 95 % confi-
dence intervals). The statistical analysis was also adjusted 
by age range, including for this purpose only women older 
than 30 years old (≥ 30 y). This decision was based on 
the assumption that women ≥ 30 y have been reported 
to be at a higher risk for acquiring persistent and clinically 
important infections and therefore may represent a better 
group for association analysis (9). The distributions of 
HPV infection were compared by the chi-square test (c2).
Of the 170 samples included in the study, 7 were dis-
carded due to degradation of the material. The remaining 
163 participants represented 10% of the sexually active 
women of Nueva Esperanza neighborhood. The median 
sample age was 31 years old (range 18-62). According to 
our survey, the population was categorized as having a 
low socio-economic level, with 96.3 % (157/163) of women 
having incomes compatible with poverty and 73.0 % 
(119/163) being unemployed. One-third of the population 
studied had not finished elementary school (51/163). We 
believe that this social context will likely affect their ability 
to access the health system. Remarkably, Pap smears 
were not available at the health center before this work 
and this study represents the first Pap attention for 35.0 
% (57/163) of the women studied. 
Pap smears showed NILM with inflammatory processes 
in 85.3 % (139/163) of the women studied and cervical 
lesions in 14.7 % (24/163). Cervical lesions reported were: 
twenty L-SIL (12.3 %), three H-SIL (1.8 %) and one ISCC 
(0.6 %). Participants with H-SIL and ISCC were surgically 
treated. 
The general prevalence of HPV infection was 38 % 
(62/163). After stratifying by Pap cytology, HPV was found 
in 33.1 % (46/139) of NILM subjects, in 100 % (4/4) of 
women with H-SIL/ISCC, and in only 60.0 % (12/20) of 
women with L-SIL. The latter result could be attributable 
to a cytological overdiagnosis. 
In order to establish regional comparisons for HPV 
prevalence in NILM women, we elaborated Table 1, which 
includes data available in other Argentinean studies (1, 4, 
5, 7, 8, 10, 12, 14, 15). The analysis of these data indicates 
that: (i) the value obtained in this work was not significantly 
different from that of a previous study performed locally 
by our group (c2p > 0.05), but was significantly higher 
than those reported for other cities in the Argentinean 
littoral region like Concordia (Entre Ríos) and Corrientes 
(Corrientes) (c2p < 0.05); (ii) the prevalence throughout 
the country is not homogeneous; (iii) the highest values 
of HPV prevalence are reported in the aboriginal popula-
tions of the country, including the Guarani communities 
of Misiones.
The prospect of prophylactic vaccines reinforces the 
need for more knowledge regarding regional prevalence 
of high-risk HPV types. In this study, a total of 14 dif-
ferent viral types were identified. Mixed infections were 
presented in 19.4 % of positive women. HPV-16 was the 
most frequent viral type among the total population with 
ten monoinfected patients and six patients with mixed 
infections; giving a total prevalence of 9.8 % (16/163). 
Moreover, HPV-16 infection was higher in women with 
cervical lesions than in the NILM, with 29.2 % (7/24) and 
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Table 1. Prevalence of HPV infection in Argentina. Analysis of selected studies.
 Location/Population HPV Source
Concordia/Urban  16.6 % (166/987) (8)
Corrientes/Urban  17.6 % (9/53) (5)
Ushuaia/Urban  26.4 % (23/87) (11)
Rosario/Urban  43.0 % (40/93) (4)
Misiones/Urban  43.0 % (92/214) (13
La Plata/Urban  46.0 % (70/152) (1)
Formosa/Indigenous  43.6 % (58/133) (Deluca G, personal communication) 
Jujuy/Indigenous  51.8 % (56/108)(1) (9) 
Misiones/Indigenous  64.2 % (133/207)(1) (15)
Misiones/Urban 33.1 % (46/139) Present Study
IARC Reference Data  20.1 % (17.7-22.7) (16)
(1) Statistically significant differences compared to the present study (c2p < 0.05)
Table 2. HPV type distribution stratified by Pap cytology.
HPV type Normal cytology   Cervical Lesions
 n=139 n=24  n=163
  n % n % n %
High-Risk      
HPV-16 6 4.3 4 16.7 10 6.1
HPV-33 10 7.2 1 4.2 11 6.8
HPV-56 5 3.6 1 4.2 6 3.8
HPV-52 6 4.3 - - 6 3.8
HPV-31 2 1.5 1 4.2 3 1.8
HPV-59 1 0.7 - - 1 0.6
HPV-58 - - 1 4.2 1 0.6
HPV-82 - - 1 4.2 1 0.6
HPV-70 1 0.7 - - 1 0.6
Subtotal High-Risk 31 22.3 9 37.5 40 24.5
Low-Risk      
HPV-6/11 2 1.5 1 4.2 3 1.8
HPV-40 1 0.7 - - 1 0.6
Subtotal Low-Risk 3 2.2 1 4.2 4 2.4
Mixed Infections       
HPV-16 + HPV-6/11 1 0.7 1 4.2 2 1.2
HPV-16 + HPV-56 1 0.7 - - 1 0.6
HPV-16 + HPV-33 1 0.7 1 4.2 2 1.2
HPV-16 + HPV-52 - - 1 4.2 1 0.6
HPV-31 + HPV-56 2 1.5 - - 2 1.2
HPV-31 + HPV-45  1 0.7 - - 1 0.6
HPV-59 + HPV-58 1 0.7 - - 1 0.6
HPV-45 + HPV-52 - - 1 4.2 1 0.6
HPV-18 + HPV-59 + HPV-58  1 0.7 - - 1 0.6
Subtotal Mixed Infections 8 5.7 4 16.7 12 7.4
Undetermined 4 2.9 2 8.0 6 3.8
Negative 93 66.9 8 33.3 101 61.9
Total 139 100 24 100 163 100
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6.5 % (9/139), respectively (c2p < 0.05), and the associ-
ated risk for infection with HPV-16 and the development 
of cervical lesions in women ≥ 30y showed an OR of 
11.8 (1.8-79.7). These results are in agreement with the 
Argentinean reference values for HPV-16 prevalence and 
are consistent with the well established role of HPV-16 
on cervical cancer development (9, 15). It is interesting to 
note that the second most frequent type was HPV-33 with 
9.3 % (13/163) between mono and co-infections, which 
was higher than the reference value for Argentina of 1.4 % 
(15). HPV type distributions are detailed in Table 2. 
Given that HPV infection is transmitted mainly by sexual 
intercourse, certain patterns of sexual behavior may be asso-
ciated with an increased risk for HPV acquisition. According 
to our survey, HPV infection was associated with the number 
of sex partners (three or more) in women ≥ 30 y. Particularly, 
HPV-16 infection was associated with the history of previous 
STDs and a smoking habit. Details are shown in Table 3.
The Screening Guidelines of the American College 
of Obstetricians and Gynecologists indicate that if 
HPV testing is used in combination with Pap smears, 
women who are negative for both tests should return to 
be controled in three years. This strategy is meant to 
minimize unnecessary follow-up visits and invasive pro-
cedures without compromising the detection of disease, 
making this scheme more appropriate to communities 
with limited access to public health services like Nueva 
Esperanza population. The National Cervical Cancer 
Prevention Program of Argentina is starting a project 
in Jujuy province, introducing the HPV test as primary 
screening (Picconi MA, personal communication). 
Therefore, the availability of new screening tools to de-
tect precancerous lesions provides great opportunities 
for cervical cancer prevention.
Despite all its limitations, this study aims to contribute 
to public health by providing epidemiological information 
about this community and implementing Pap screening. 
These data can also be useful for the implementation 
of prevention programs, including an appropriate intro-
duction of vaccination and the baseline for virological 
surveillance in the vaccine era.
Conflict of Interest: The authors have no conflicts of inter-
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Table 3. Evaluation of risk factors for HPV infection and the development of cervical lesions in the population studied.
 HPV OR HPV-16 OR Normal Cervical OR
 (+) (-) (CI 95%) (+) (-) (CI 95%) cytology lesions (CI 95%)
Age at first intercourse
≥19 8 14 1  2 20 1  21 1 1
≤18 54 86 1.1 (0.4-2.8) 15 125 1.2 (0.2-5.6) 117 23 4.1 (0.5-32.2)
   1.0 (0.4-2.9)(2)   0.4 (0.1-2.5)(2)   3.7 (0.4-30.6)(2)
Lifetime no. of Sex Partners         
1-2 37 73 1  9 101 1  96 14 1
≥3 25 25 2.0 (1.0-3.9) 8 42 2.1 (0.8-5.9) 40 10 1.7 (0.7-4.2)
   4.2 (1.6-10.8)(1,2)   4.0 (0.6-25.4)(2)   2.4 (0.7-8.0)(2)
Parity         
1-2 14 25 1  5 34 1 31 8 1
≥3 48 76 1.1 (0.5-2.4) 12 112 0.7 (0.2-2.2) 108 16 0.6 (0.2-1.5)
   0.9 (0.3-3.1)(2)   0.7 (0.1-6.6)(2)   1.0 (0.2-4.8)(2)
History of STIs         
No 55 90 1  12 133 1 125 20 1
Yes 7 9 1.3 (0.4-3.6) 5 11 5.0 (1.5-16.9)(1, 2) 12 4 2.1 (0.6-7.1)
   0.9 (0.2-3.9)(2)   7.8 (1.1-54.8)(1, 2)   3.7 (0.8-17.4)(2)
Smoking         
No 47 78 1  11 114 1 105 20 1
Yes 15 18 1.4 (0.6-3.0) 6 27 2.3 (0.8-6.8) 29 4 0.7 (0.2-2.3)
   1.4 (0.5-3.8)(2)   6.6 (1.0-42.6)(1, 2)   1.2 (0.3-4.7)(2)
Pap Smears
Normal 46 93 1  10 129 1
Cervical Lesions 16 8 4.0 (1.6-10.1)(1) 7 17 5.3 (1.8-15.8)
   8.4 (2.1-33.3)(1, 2)   11.8 (1.8-79.7)(1, 2)
(1) Statistically significant differences; (2)Odds ratios adjusted by age (≥30y).
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